Clinical trial
Directly Observed Therapy (DOT) in HIV-1 Infected Adolescents
NCT00259389 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Directly Observed Therapy (DOT) in HIV-1 Infected Adolescents
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- September 30, 2007
- Enrollment
- 24 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.